Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 34 best rare earth metal stocks of the very few that mine this essential strategic resource.
To be a shareholder in Interface, I would need to see value in its ability to expand beyond its core U.S. market and maintain its edge in sustainable and innovative flooring, especially as global competition remains fierce. The latest upward guidance revision, while reflecting continued strength in healthcare and automation, is incremental, and does not materially alter the balance between near-term momentum from healthcare growth and the heightened risk of overreliance on the U.S. commercial market.
Among Interface's recent announcements, its Q3 2025 results stand out, with revenue and earnings exceeding expectations, again buoyed by healthcare segment gains. This performance aligns directly with the most important current catalyst: broadening end-market demand, particularly in healthcare, which complements ongoing automation-driven productivity improvements and provides a clearer path toward margin expansion.
But as demand shifts and international exposure remains limited, investors should also consider the implications if U.S. commercial real estate activity slows...
Read the full narrative on Interface (it's free!)
Interface's narrative projects $1.6 billion revenue and $133.7 million earnings by 2028. This requires 5.3% yearly revenue growth and a $37.7 million earnings increase from $96.0 million today.
Uncover how Interface's forecasts yield a $32.67 fair value, a 27% upside to its current price.
Simply Wall St Community members set TILE's fair value between US$19.82 and US$56.43, based on four independent estimates. With healthcare as an engine of interface's current momentum, these diverging appraisals underline the range of expectations around its future trajectory.
Explore 4 other fair value estimates on Interface - why the stock might be worth over 2x more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com